PBM Reporting Transparency Act

The PBM Reporting Transparency Act would require the Medicare Payment Advisory Commission (MedPAC) to submit two reports to Congress on agreements between pharmacy benefit managers (PBMs) and prescription drug plans or MA–PD plans. The initial report, due within two years after the Secretary makes relevant data available to MedPAC, would analyze trends in PBM agreements, their effects on enrollee out-of-pocket costs and pharmacy reimbursement, and include any appropriate recommendations. A final report, due two years after the initial report, would describe changes in these agreements over time and include further recommendations as determined by MedPAC. The bill affects PBMs, prescription…

AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.